HEART FAILURE MODELS
Reproducible heart failure models for your pipelines.
Every year in the United States alone, 100,000 people die of blood clots. That’s 274 deaths every day of the year. Thrombotic events are also the leading cause of mortality in pregnant women both during their pregnancy and post-delivery, and the leading cause of death in people with cancer after the cancer itself.
At PharmaLegacy, we believe this needs to change. Our models are designed to tackle all the different facets of thrombosis, and this is ensured by providing a range of different options. Our preclinical platforms faithfully reproduce platelet function, fibrinolysis, coagulation, hematologic parameters, and hemodynamics; in other words, they ensure proper translatability from the animal model to the clinical setting.
Get in touch now, and let’s get your thrombosis pipeline moving.
MODELS / SERVICES
Case Study: Rat Model of Myocardial Infarction (MI)
A clinically predictive model for acute or chronic heart failure is used to test resembling changes in physiopathology and histopathology in the development of heart failure post MI in humans, and to predict responses to pharmacologic interventions.
Clinical Parameters
Echocardiograph (M mode)
Reactive Fibrosis
Committed to quality:
- 24/7 access to PharmaLegacy representatives
- AAALAC and CNAS guidelines-adherent animal studies
- Research data electronically managed by BioBook (IDBS, UK)
- Clients have real-time remote monitoring of studies
If you are looking for comprehensive preclinical development services, you are at the right place. Get in touch with our team of highly trained professionals and let’s get your pipeline moving.
We’re ready when you are.
Tell us your pharmacology challenges.
